DTSQ Purchaser Inc.
Amendment No. 1 to Form S-4 registers up to 57,885,247 Class A shares and 1,931,900 non-redemption warrants of DTSQ Purchaser Inc. (to be renamed PrimeGen Holdings). The proxy/prospectus covers the business combination between DT Cloud Star Acquisition Corp. (DTCS) and PrimeGen US, Inc. (PGUS), signed February 2, 2026 and amended November 10, 2026. Purchase price is $1,489,800,000, with 105,687,444 Pubco shares issued as merger consideration at a $11.05 redemption price.
- Purchase price for PGUS is $1,489,800,000, less adjustments for PGUS warrants and options.
- Merger consideration totals 105,687,444 Pubco shares: 19,702,841 Class A and 85,984,603 Class B.
- Non-redemption warrants: 1,931,900 issued at $2.00 exercise price, exercisable 6-24 months post-closing.
- Trust account held approximately $18.3 million as of June 10, 2026 after 76.05% of public shares were redeemed.
- Outside date is January 31, 2027, extendable to April 30, 2027 with shareholder approval.
Price data unavailable.
A $1.49B SPAC merger where 76% of public shares already redeemed, leaving a thin ~$18.3M trust to support the deal.
SPAC business combination with a biotech (SIC 2836) target, following heavy redemptions that shrank the trust to ~$18.3M.
Nasdaq listing approval is a closing condition and cannot be assured; failure would block the combination unless waived. Sponsor compensation and securities issuance may materially dilute non-redeeming public shareholders.